USPTO serial 79375404
TOKAMAK ENERGY
Reviewed by CopyMark Law Group
Status 654
- Filing date
- Status date
- Registration date
- —
- Examiner
- HILLIARD, JESSICA LYNN
- Law office
- TMO LAW OFFICE 120
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with TOKAMAK ENERGY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
J ROB LEBLANC
J ROB LEBLANC Greenberg Traurig, LLP2200 Ross Avenue, Suite 5200Dallas, TX 75201United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific, research, surveying, photographic, audiovisual, optical, weighing, measuring, signalling, detecting, testing, inspecting, and teaching apparatus and instruments, namely, devices in the field of fusion technologies; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling the distribution or use of electricity; magnets; electromagnets; superconductive magnets; apparatus and instruments for transmitting, reproducing or processing sound, images or data; downloadable and recorded computer software for managing and operating fusion technologies, fusion apparatus and instruments, or HTS superconducting magnets and associated systems; structural and replacement parts and fittings therefor for the aforementioned goods; none of the aforementioned goods relating to subscription management for billing and payment solutions; none of the aforesaid goods for use in relation to financial transactions, banking, investment services, or in the field of credit unions; none of the aforesaid goods for use in relation to clinical trials, medicine, drug approval, or pharmaceuticals; none of the aforesaid goods for use in cryptocurrencies, digital currencies, virtual currencies, digital tokens, digital assets, cryptoassets, cryptographic assets, stablecoins, decentralized applications (DApps), or blockchain | ACTIVE | — |
| 011 | Nuclear generators; nuclear installations in the nature of nuclear fusion reactors; nuclear reactors; installations in the nature of nuclear power plants, nuclear generators, and nuclear reactors for processing nuclear fuel and nuclear moderating material; toroidal nuclear fusion reactors; desalination installations and desalination apparatus; structural and replacement parts and fittings therefor for the aforementioned goods; none of the aforesaid goods for use in relation to financial transactions, banking, investment services, or in the field of credit unions; none of the aforesaid goods for use in relation to clinical trials, medicine, drug approval, or pharmaceuticals; none of the aforesaid goods for use in cryptocurrencies, digital currencies, virtual currencies, digital tokens, digital assets, cryptoassets, cryptographic assets, stablecoins, decentralized applications (DApps), or blockchain | ACTIVE | — |
| 040 | Production of energy and production of energy in the form of heat; generation of energy and generation of energy in the form of heat; conversion of nuclear fuels in the nature of nuclear fuel recycling for nuclear fuel generation, nuclear waste treatment and destruction of waste; processing of nuclear fuels; electricity generation; provision of information relating to production of energy and conversion of nuclear fuels in the nature of nuclear fuel recycling for nuclear fuel generation, nuclear waste treatment, and destruction of waste; provision of information relating to processing of nuclear fuels and electricity generation; desalination of water; consultancy, advisory and information services relating to all of the aforementioned services; none of the aforesaid services for use in relation to financial transactions, banking, investment services, or in the field of credit unions; none of the aforesaid services for use in relation to clinical trials, medicine, drug approval, or pharmaceuticals; none of the aforesaid services for use in cryptocurrencies, digital currencies, virtual currencies, digital tokens, digital assets, cryptoassets, cryptographic assets, stablecoins, decentralized applications (DApps), or blockchain | ACTIVE | — |
| 042 | Consultancy services relating to nuclear engineering; nuclear engineering services; engineering services; scientific and technological services, namely, scientific research, analysis, testing in the fields of power generation technology and experimental nuclear fusion and commercial nuclear fusion; scientific research relating to nuclear engineering; design and development of devices for electricity generation; research and development of products for electricity generation; engineering services for the design of structures for electricity generation; scientific and technological services, namely, design of engineering products for the purposes of electricity generation; design and development of high temperature superconducting magnets; scientific and technological services, namely, scientific research and engineering design in the field of plasma physics; provision of information relating to nuclear engineering, engineering and technology consultation in the fields of electrical engineering, and power, heat, and electricity generation in experimental or commercial fusion; design and development of computer hardware and software; consultancy, advisory and information services relating to all of the aforementioned services; none of the aforementioned services relating to subscription management for billing and payment solutions; none of the aforesaid services for use in relation to financial transactions, banking, investment services, or in the field of credit unions; none of the aforesaid services for use in relation to clinical trials, medicine, drug approval, or pharmaceuticals; none of the aforesaid services for use in cryptocurrencies, digital currencies, virtual currencies, digital tokens, digital assets, cryptoassets, cryptographic assets, stablecoins, decentralized applications (DApps), or blockchain | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 25, 2026 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 4, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Aug 3, 2025 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Apr 22, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 22, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 22, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 22, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 22, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 31, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 31, 2025 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jan 10, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Dec 25, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 25, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jul 17, 2024 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 17, 2024 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 17, 2024 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 4, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 4, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 4, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 26, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 4, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 4, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 3, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 2, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 28, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 27, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |